Platform
Features
0 followers
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Employees
Links
Marie Labus
4 members
5 members
Vaxcyte
2 followers
89bio
BioTeam
The Academy of Medical Sciences
1 follower
University College London
16 followers
Volt
4 followers
eGenesis
elasticStage
3 followers
Thermo Fisher Scientific
167 followers
Genentech
150 followers
Gilead Sciences
128 followers
Explore companies